The company agreed to add “about 100 million doses” to the governing body “for Mayo finals”, and ensure that it can be completed.
During the past week, a scandal has erupted to reveal that a lot of 15 million doses of medium-sized media has been mistaken for a plant in Baltimore.
The ingredients used in the manufacture of another vacuum cleaner, AstraZeneca’s, are mixed with the Johnson & Johnson vacuum cleaner, says the diary “The New York Times”.
The error was detected by the quality control and the defective dose only in the plant, which awaits the official approval of the authorities to administer the vaccine.
Since then, AstraZeneca’s pharmaceutical production has been withdrawn from the plant, managed by the Emergent BioSolutions company, and Johnson & Johnson’s supervisors review the operations.
“Johnson & Johnson assumes liability” for the incident, said the company’s company in a communication on Saturday, claiming that it was “working hard” with the Food and Drug Administration (FDA) to obtain the approval vacuna in the Baltimore plant.
The Johnson & Johnson vaccine, which has the large logistical management dose in one dose, received the United States Emergency Approval in the February finals, between Pfizer / BioNTech and Moderna.
Johnson & Johnson donated 20 million to the United States in the March finals, as agreed, and “the company agreed to buy 24 million in the April finals”, said Jeff Zients last week, coordinator of the Casa Blanca antipandemia strategy .
“Moderna and Pfizer are now on a stable cadence (of entregas) week after week. So it’s not like Johnson & Johnson has a lorddo todavía”, reconoció.